NCT05974410 2025-10-02Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAVM Biotechnology IncAvailable
NCT01200017 2021-05-27Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell TransplantUniversity of California, San FranciscoNo longer available
NCT02715843 2019-10-11Extended Treatment Access Study of MT-3724 for Subjects With Relapsed Non-Hodgkin's B-Cell LymphomaMolecular Templates, Inc.No longer available
NCT00481559 2014-01-17Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate ToxicityBTG International Inc.Approved for marketing